Related Experiment Video
Updated: May 16, 2026
09:19
Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
Published on: December 8, 2017
Cannabinoid modulation of neuroinflammatory disorders.
Viviane M Saito1, Rafael M Rezende, Antonio L Teixeira
1Laboratory of Immunopharmacology, Graduate Program in Neurosciences, UFMG, Belo Horizonte, Brazil.
Current Neuropharmacology
|December 4, 2012
Summary
The endocannabinoid system, involving compounds like Δ(9)-tetrahydrocannabinol (THC), modulates neurotransmitters and inflammation. Cannabinoids show therapeutic potential for neuroinflammatory diseases, especially multiple sclerosis.
Area of Science:
- Neuroscience
- Pharmacology
- Immunology
Background:
- The endocannabinoid system is a key regulator of neurotransmission and biological processes.
- Cannabis sativa compounds, notably Δ(9)-tetrahydrocannabinol (THC), interact with this system.
- Neuroinflammation is implicated in various diseases, including neurodegenerative disorders.
Purpose of the Study:
- To review the historical and biochemical aspects of cannabinoids.
- To explore the role of cannabinoids in modulating inflammatory responses.
- To discuss the therapeutic potential of cannabinoids for neuroinflammatory diseases, with a focus on multiple sclerosis.
Main Methods:
- Literature review of scientific publications.
- Analysis of historical data on cannabinoid research.
- Biochemical and functional assessment of cannabinoid actions.
- Evaluation of therapeutic strategies for neurodegenerative conditions.
Main Results:
- Cannabinoids modulate neurotransmitter release and inflammatory pathways.
- Δ(9)-tetrahydrocannabinol (THC) is a primary psychoactive compound with immunomodulatory effects.
- Evidence suggests cannabinoids may offer therapeutic benefits in managing neuroinflammation.
Conclusions:
- The endocannabinoid system presents a promising target for treating neuroinflammatory conditions.
- Cannabinoids, particularly THC, demonstrate potential as therapeutic agents for multiple sclerosis.
- Further research is warranted to fully elucidate cannabinoid mechanisms and optimize therapeutic applications.
Related Concept Videos
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...